View Older Stories View More Recent Stories

Jul 13, 2023 04:30PM Form 13F-HR Canaan Partners X LLC For: Jun 30
Jul 13, 2023 04:30PM Form 13F-HR Canaan Partners XI LLC For: Jun 30
Jun 20, 2023 09:00AM World View Names New Chief Financial Officer and Appoints New Member to Its Board of Directors
Jun 2, 2023 10:00AM CircleUp Acquired by Brightflow AI
Jun 1, 2023 05:50PM Brightflow AI Acquires CircleUp to Deepen Customer Insights and Help Small Businesses Grow
May 18, 2023 08:00AM OncoResponse Awarded $13 Million in Funding from CPRIT and Raises $14 Million in Added Funds from Investors to Advance Cancer Immunotherapy
May 10, 2023 09:30AM Lev Announces the Launch of Lev Match
Apr 27, 2023 07:00AM Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO
Apr 19, 2023 09:00AM OncoResponse Presents at AACR 2023 Annual Meeting Preclinical Data Highlighting Dual Antagonist Antibodies Targeting both LILRB1 and LILRB2
Apr 19, 2023 09:00AM Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
Apr 19, 2023 09:00AM Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
Apr 17, 2023 07:00AM Pathios Therapeutics Unveils PTT-4256, a Highly Potent and Selective Inhibitor of GPR65, in Presentation at American Association for Cancer Research (AACR) Annual Meeting 2023
Apr 16, 2023 03:30PM Researchers Report Clinical Proof-of-Concept Data for Vivace Therapeutics' VT3989, a First for a Cancer Drug Targeting the Hippo Pathway, in Oral Presentation at AACR 2023
Apr 6, 2023 04:31PM Form 13F-HR Canaan Partners XI LLC For: Mar 31
Apr 6, 2023 04:30PM Form 13F-HR Canaan Partners X LLC For: Mar 31
Mar 30, 2023 07:00AM ThirtyFiveBio Emerges From Stealth with Presentation of First Data from GPR35 Antagonist Program at American Association for Cancer Research (AACR) Annual Meeting 2023
Mar 15, 2023 02:05PM OncoResponse Announces Presentation of Preclinical Data on Dual Antibodies Targeting LILRB1 and LILRB2 at American Association for Cancer Research Annual Meeting 2023 (AACR 2023)
Mar 15, 2023 07:30AM Vivace Therapeutics to Unveil First Clinical Data for a Cancer Drug Targeting the Hippo Pathway
Feb 14, 2023 07:00AM Halda Therapeutics unveils its first pipeline data for RIPTAC™ therapeutics, a new drug modality, at ASCO GU Symposium
Feb 1, 2023 04:32PM Form 13F-HR Canaan Partners X LLC For: Dec 31
Feb 1, 2023 04:31PM Form 13F-HR Canaan Partners IX LLC For: Sep 30
Feb 1, 2023 04:31PM Form 13F-HR Canaan Partners XI LLC For: Dec 31
Jan 31, 2023 03:08PM Appsmith Launches Partner Program to Empower Businesses to Build Business Critical Applications
Jan 24, 2023 08:00AM Komprise Raises $37M to Fuel Growth and Advance Leadership in Unstructured Data Management
Jan 11, 2023 08:00AM Kraken Appoints Dan Ciporin to Board of Directors
Jan 5, 2023 08:00AM OncoResponse to Present at 41st Annual J.P. Morgan Healthcare Conference
Dec 8, 2022 09:01AM neonVest Closes Seed Round Led by 7BC Venture Capital for Their SaaS-Based Startup Scaling Platform
Dec 1, 2022 08:07AM Lynne Laube, Founder and Former CEO of Cardlytics, Joins Valor Ventures as Operating Partner
Nov 30, 2022 07:00AM Pathios Therapeutics Appoints Jeanmarie Guenot, Ph.D., as Non-Executive Director
Nov 11, 2022 09:00AM OncoResponse Announces Preclinical Data Highlighting OR2805 Discovery from Elite Responder Platform and OR502 anti-LILRB2 Antibody at SITC 2022
Nov 10, 2022 09:25AM Fineqia Sees 7x Uplift in Investment Value in IDEO CoLab Ventures Fund I; No Exposure to FTX
Nov 3, 2022 07:00AM Pathios Therapeutics to Present Preclinical Data Highlighting Potential of GPR65 Inhibition as a Powerful Anti-Tumor Immunotherapy Strategy at SITC 2022
Nov 2, 2022 09:00AM Amid Rapid Growth, Lev Announces a Wave of Executive Hires, Appointing a Vice President of Marketing, Vice President of Product and Head of People
Oct 31, 2022 01:17PM Form 13F-HR Canaan Partners X LLC For: Sep 30
Oct 31, 2022 01:16PM Form 13F-HR Canaan Partners XI LLC For: Sep 30
Sep 7, 2022 08:00AM OncoResponse Announces Clinical Supply Agreement with Regeneron to Evaluate OR2805 in Combination with Libtayo® (cemiplimab) in Patients with Advanced Cancer
Aug 24, 2022 12:00PM Lily AI Closes $25M Series B to Bring the Language of the Customer Across the Entire Retail Value Chain
Aug 18, 2022 09:00AM $16.7 Million Cash Out Refinance Loan Secured by Lev Brokers for TIR Equities in Birmingham, Michigan
Aug 17, 2022 09:00AM Lev Secures $41.5 Million in Cannabis CRE Financing Across the U.S., Breaking Down Barriers to Federal Loans in the Market
Aug 10, 2022 03:12PM Form 13F-HR Canaan Partners XI LLC For: Jun 30
Aug 10, 2022 03:08PM Form 13F-HR Canaan Partners X LLC For: Jun 30
Aug 10, 2022 02:59PM Form 13F-HR Canaan Partners IX LLC For: Jun 30
Aug 9, 2022 09:00AM Lev Brokers Secure $2.3 Million Loan for Durham, NC Townhomes
Jul 28, 2022 09:00AM $17.5 Million Construction-to-Permanent Financing Secured by Lev Brokers in Chesterfield, Michigan
Jun 28, 2022 09:32AM Hank Debuts Platform to Connect Adults 55+ with In-Person Experiences and Community
Jun 21, 2022 04:07PM Aziyo Biologics (AZYO) Appoints Dr. C. Randal Mills as Interim President and CEO
Jun 21, 2022 04:05PM Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO
Jun 8, 2022 09:00AM Lev Brokers Secure $11.7 Million Bridge Refinance Deal for Houston Multifamily Apartment Complex
Jun 2, 2022 11:00AM Edge Impulse Announces Appointment of Simon Segars to Board of Directors
May 17, 2022 12:00PM Jina AI Shapes Future of Search as CB Insights Names it in 100 Most Innovative AI Startups for Second Year Running
View More Recent Stories View Older Stories